IEFV:LSE:LSE-iShares MSCI Europe Value Factor UCITS (GBX)

ETF | Others |

Last Closing

USD 751.4

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.08M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+4.00 (+2.23%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.34 (+2.63%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.62 (+3.68%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+2.65 (+2.43%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.25 (+1.77%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+1.01 (+3.54%)

USD 259.48B
0QZO:LSE 0QZO

+1.55 (+1.85%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+4.50 (+3.32%)

USD 202.26B
0R24:LSE Intel Corp.

+1.47 (+7.84%)

USD 196.14B

ETFs Containing IEFV:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.08% 86% B+ 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.08% 85% B 80% B-
Trailing 12 Months  
Capital Gain 5.16% 82% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.16% 79% B- 73% C
Trailing 5 Years  
Capital Gain 83.45% 79% B- 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.45% 77% C+ 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 12.30% 72% C 73% C
Dividend Return 12.30% 71% C- 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.49% 63% D 79% B-
Risk Adjusted Return 117.28% 96% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike